Data networks are playing an increasingly important role in driving diversity strategies for clinical trials. How can the industry ensure clinical trials are available in areas where patients need them most? Join us for a webinar on Aug. 8 as we explore the importance of territory mapping and how it could save time and money on drug development. Learn about how data networks can help maximize diversity and efficiency in clinical trials. Register here ⇢ https://bit.ly/45aKSFa

Data networks are playing an increasingly important role in driving diversity strategies for clinical trials. How can the industry ensure clinical trials are available in areas where patients need them most? Join us for a webinar on Aug. 8 as we explore the importance of territory mapping and how it could save time and money on drug development. Learn about how data networks can help maximize diversity and efficiency in clinical trials. Register here ⇢ https://bit.ly/45aKSFa

From accelerated timelines to cost savings, find out how our co-located state-of-the-art #bioanalyticallab and #clinicalpharmacologyunit can help your program reach its clinical milestones. https://bit.ly/3Vii5Nb

From accelerated timelines to cost savings, find out how our co-located state-of-the-art #bioanalyticallab and #clinicalpharmacologyunit can help your program reach its clinical milestones. https://bit.ly/3Vii5Nb

Register below for our March 27 webinar on scaling Clin Dev Insights with expert Kwame Marfo.

Incorporating the patient voice in market access https://lnkd.in/ghP2Kq_D This article explores the evolving patient-centric approaches within biopharma market access, enabling you to: understand how patients can be involved throughout the product lifecycle determine the influence of the patient voice in regulatory and HTA activities learn how manufacturers and patients/advocacy groups can work in partnership. Download your copy: https://lnkd.in/ghP2Kq_D #MarketAccess #HEOR #WeAreAvalereHealth

Let us show you how to leverage your clinical outcome assessment (COA) strategy for multiple stakeholders. Discover the true value of your COA data for new treatments beyond labelling by joining our interactive ISPOR virtual short course: ‘Leveraging clinical outcome assessment (COA) data to maximise the value of new treatments beyond labelling’. This online course, led by COA experts, will run between 11am and 1pm EDT on 26 and 27 June — complete with interactive conversations about the power of your COA data. Will you be joining us? #ISPOR #pharma #healthcare

From accelerated timelines to cost savings, find out how our co-located state-of-the-art #bioanalyticallab and #clinicalpharmacologyunit can help your program reach its clinical milestones. https://bit.ly/3Vii5Nb

From accelerated timelines to cost savings, find out how our co-located state-of-the-art #bioanalyticallab and #clinicalpharmacologyunit can help your program reach its clinical milestones. https://bit.ly/3Vii5Nb

From accelerated timelines to cost savings, find out how our co-located state-of-the-art #bioanalyticallab and #clinicalpharmacologyunit can help your program reach its clinical milestones. https://bit.ly/3Vii5Nb